Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

B-Cell Receptor Signaling Drives Glycolysis in Chronic Lymphocytic Leukemia Cells

Andrew James Clear, BSc, Annalisa D'Avola, PhD, Samir G. Agrawal, BSc, PhD MBChB, Laura Z. Rassenti, PhD, Thomas J. Kipps, MD PhD, John G. Gribben, John Riches, MD PhD

Blood (2018) 132 (Supplement 1): 3121.

https://doi.org/10.1182/blood-2018-99-112860

Published: 2018

Journal Articles

A Double-Blind, Multicentre, Randomised, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome®) for the Prevention of Invasive Fungal Infections in Subjects Receiving Remission-Induction Chemotherapy for Acute Lymphoblastic Leukaemia (AmBiGuard trial)

Oliver Cornely, MD, Thibaut Leguay, MD, Johan Maertens, MD, Carlo Castagnola, MD, Achilles Anagnostopoulos, Bernadino Allione, MD, Claus Peter Heussel, MD, J Peter Donnelly, PhD, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, MD, Nicola Goekbuget, MD

Blood (2014) 124 (21): 3646.

https://doi.org/10.1182/blood.V124.21.3646.3646

Published: 2014

Journal Articles

Soluble CD23 (sCD23): A Forgotten Indicator of Prognosis and Identifier of Outcome in Patients with Chronic Lymphocytic Leukemia Utilizing a Novel Cba Approach

Timothy William Farren, Fengting Liu, Magali Le Garff-Tavernier, MD PhD, Marika Sarfati, Frans Nauwelaers, Jim Keenan, Noel Warner, Helene Merle-Beral, Samir G. Agrawal

Blood (2014) 124 (21): 1949.

https://doi.org/10.1182/blood.V124.21.1949.1949

Published: 2014

Journal Articles

Tocilizumab Overcomes Chemo-Resistance Of CLL Cells

Fengting Liu, MD Ph.D, Li Jia, PhD, MD, Ping Wang, MD, Tim Farren, PhD, Samir G Agrawal, MD, PhD

Blood (2013) 122 (21): 5305.

https://doi.org/10.1182/blood.V122.21.5305.5305

Published: 2013

Journal Articles

NK Cells From CLL Patients Exhibit Down-Regulation Of Interferon Response Genes That Can Be Reversed With Lenalidomide

John C. Riches, MD, Ajanthah Sangaralingam, PhD, Tracy Chaplin, Fabienne McClanahan, MD, Sameena Iqbal, Samir G. Agrawal, Alan G. Ramsay, PhD, John Gribben, MD, DSc

Blood (2013) 122 (21): 4131.

https://doi.org/10.1182/blood.V122.21.4131.4131

Published: 2013

Journal Articles

Combined ROR1 and CD160 Detection For Improved Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia (CLL)

Timothy W. Farren, Ph.D, Fengting Liu, MD Ph.D, Marion G. Macey, Ph.D, Thomas J. Kipps, MD, PhD, Noel Warner, Samir G. Agrawal

Blood (2013) 122 (21): 2572.

https://doi.org/10.1182/blood.V122.21.2572.2572

Published: 2013

Journal Articles

Both PI3K p110α and p110δ Isoforms Control CD160-Mediated CLL Cell Viability and Cytokine Production

Timothy W. Farren, Ph.D, Fengting Liu, MD Ph.D, Samir G. Agrawal

Blood (2013) 122 (21): 4124.

https://doi.org/10.1182/blood.V122.21.4124.4124

Published: 2013

Journal Articles

Effectiveness Of Biosimilar Epoetin Alfa For The Treatment Of Chemotherapy-Induced Anemia In Patients With Hematological Malignancies

Samir G. Agrawal, Andrea Guy, Patricia O'Flaherty, Matthew Turner

Blood (2013) 122 (21): 3430.

https://doi.org/10.1182/blood.V122.21.3430.3430

Published: 2013

Journal Articles

Use Of Biosimilar G-CSF Compared With Lenograstim In Autologous Haematopoietic Stem Cell Transplant and In Sibling Allogeneic Transplant

Shab Uddin, Pippa Russell, Maresa Farrell, Barbara Davy, Samir G. Agrawal

Blood (2013) 122 (21): 2170.

https://doi.org/10.1182/blood.V122.21.2170.2170

Published: 2013

Journal Articles

Autocrine IL-6 Production Indicates the Level of Activated STAT3 and NF-Kb of Chronic Lymphocytic Leukemia Cells

Fengting Liu, Li Jia, MD, PhD, Timothy W Farren, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD

Blood (2011) 118 (21): 1784.

https://doi.org/10.1182/blood.V118.21.1784.1784

Published: 2011

Journal Articles

Differential and tumor-specific expression of CD160 in B-cell malignancies

Timothy W. Farren, Jerome Giustiniani, Feng-Ting Liu, Dimitris A. Tsitsikas, Marion G. Macey, James D. Cavenagh, Heather E. Oakervee, David Taussig, Adrian C. Newland, Maria Calaminici, Armand Bensussan, Michael Jenner, John G. Gribben, Samir G. Agrawal

Blood (2011) 118 (8): 2174–2183.

https://doi.org/10.1182/blood-2011-02-334326

Published: 2011

Includes: Supplemental data

Journal Articles

A Phase II Trial of Sequential Treatment with Cytoreductive Therapy and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukaemia, High-Risk MDS and Other High Risk Myeoid Malignancies: An Interim Report.

Dimitris A Tsitsikas, Dana Warcel-Sibony, Heather E. Oakervee, MBBS, BSc, MD, MRCP, FRCPath, Samir G Agrawal, Matthew Smith, David C Taussig, PhD, MRCP, FRCPath, Johannes de Vos, Elaine Stewart, Hannah Nicholas, John G. Gribben, MD, DSc, James D Cavenagh

Blood (2010) 116 (21): 3480.

https://doi.org/10.1182/blood.V116.21.3480.3480

Published: 2010

Journal Articles

CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia

Feng-Ting Liu, Jerome Giustiniani, Timothy Farren, Li Jia, Armand Bensussan, John G. Gribben, Samir G. Agrawal

Blood (2010) 115 (15): 3079–3088.

https://doi.org/10.1182/blood-2009-08-239483

Published: 2010

Includes: Supplemental data

Journal Articles

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34 − fraction

David C. Taussig, Jacques Vargaftig, Farideh Miraki-Moud, Emmanuel Griessinger, Kirsty Sharrock, Tina Luke, Debra Lillington, Heather Oakervee, Jamie Cavenagh, Samir G. Agrawal, T. Andrew Lister, John G. Gribben, Dominique Bonnet

Blood (2010) 115 (10): 1976–1984.

https://doi.org/10.1182/blood-2009-02-206565

Published: 2010

Includes: Supplemental data

Journal Articles

Expression of Surface IgG Is High in Chronic Lymphocytic Leukaemia, and Co-Expression with IgM Confers a Worse Prognosis.

Tom Butler, MBChB, FRCPath, Catherine Wiseman, BSc(Hons), MPhil, Timothy Farren, BSc(HONS), MIBMS, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD

Blood (2009) 114 (22): 4371.

https://doi.org/10.1182/blood.V114.22.4371.4371

Published: 2009

Journal Articles

Spontaneous in Vitro Death of CLL Cells Can Be Prevented by Mitochondrial Stabilization Via CD160 Signaling.

Feng-Ting Liu, MB, PhD, Li Jia, MB, PhD, Timothy Farren, BSc(HONS), MIBMS, Jerome Giustiniani, Armand Bensussan, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD

Blood (2009) 114 (22): 4372.

https://doi.org/10.1182/blood.V114.22.4372.4372

Published: 2009

Journal Articles

CD160 Expression in B-Cell Lymphoproliferative Disorders: Derivation and Validation of a New Three-Antigen Scoring System Improving Diagnostic Precision in B-Cell Malignancies.

Timothy W Farren, BSc(HONS), MIBMS, Feng-Ting Liu, MB, PhD, Claire Stephens, MSc, Dimitris Tsitsikas, MBBS, MRCP, Marion G Macey, PhD, FRCPath, Michael Jenner, MD, PhD, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD

Blood (2009) 114 (22): 4382.

https://doi.org/10.1182/blood.V114.22.4382.4382

Published: 2009

Journal Articles

Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib

Feng-Ting Liu, Samir G. Agrawal, Zanyar Movasaghi, Peter B. Wyatt, Ihtesham U. Rehman, John G. Gribben, Adrian C. Newland, Li Jia

Blood (2008) 112 (9): 3835–3846.

https://doi.org/10.1182/blood-2008-04-150227

Published: 2008

Includes: Supplemental data

Journal Articles

Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells

David C. Taussig, Farideh Miraki-Moud, Fernando Anjos-Afonso, Daniel J. Pearce, Kirsty Allen, Christopher Ridler, Debra Lillington, Heather Oakervee, Jamie Cavenagh, Samir G. Agrawal, T. Andrew Lister, John G. Gribben, Dominique Bonnet

Blood (2008) 112 (3): 568–575.

https://doi.org/10.1182/blood-2007-10-118331

Published: 2008

Includes: Supplemental data

Journal Articles

Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia

Samir G. Agrawal, Feng-Ting Liu, Catherine Wiseman, Sima Shirali, Hongxiang Liu, Debra Lillington, Ming-Qing Du, Denise Syndercombe-Court, Adrian C. Newland, John G. Gribben, Li Jia

Blood (2008) 111 (5): 2790–2796.

https://doi.org/10.1182/blood-2007-10-110460

Published: 2008

NARROW

B-Cell Receptor Signaling Drives Glycolysis in Chronic Lymphocytic Leukemia Cells

Soluble CD23 (sCD23): A Forgotten Indicator of Prognosis and Identifier of Outcome in Patients with Chronic Lymphocytic Leukemia Utilizing a Novel Cba Approach

Tocilizumab Overcomes Chemo-Resistance Of CLL Cells

NK Cells From CLL Patients Exhibit Down-Regulation Of Interferon Response Genes That Can Be Reversed With Lenalidomide

Combined ROR1 and CD160 Detection For Improved Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia (CLL)

Both PI3K p110α and p110δ Isoforms Control CD160-Mediated CLL Cell Viability and Cytokine Production

Effectiveness Of Biosimilar Epoetin Alfa For The Treatment Of Chemotherapy-Induced Anemia In Patients With Hematological Malignancies

Use Of Biosimilar G-CSF Compared With Lenograstim In Autologous Haematopoietic Stem Cell Transplant and In Sibling Allogeneic Transplant

Autocrine IL-6 Production Indicates the Level of Activated STAT3 and NF-Kb of Chronic Lymphocytic Leukemia Cells

Differential and tumor-specific expression of CD160 in B-cell malignancies

A Phase II Trial of Sequential Treatment with Cytoreductive Therapy and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukaemia, High-Risk MDS and Other High Risk Myeoid Malignancies: An Interim Report.

CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34 − fraction

Expression of Surface IgG Is High in Chronic Lymphocytic Leukaemia, and Co-Expression with IgM Confers a Worse Prognosis.

Spontaneous in Vitro Death of CLL Cells Can Be Prevented by Mitochondrial Stabilization Via CD160 Signaling.

CD160 Expression in B-Cell Lymphoproliferative Disorders: Derivation and Validation of a New Three-Antigen Scoring System Improving Diagnostic Precision in B-Cell Malignancies.

Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib

Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells

Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only